^
    Back
    Association details:
    Biomarker:ADAMTS1 expression
    Cancer:Prostate Cancer
    Drug:docetaxel (Tubulin polymerization promoter, Microtubule stabilizer)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    Source:
    Front Oncol
    Title:

    The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer

    Published date:
    01/16/2023
    Excerpt:
    In mHSPC patients, expression of KLK2, KLK4, ADAMTS1, ZEB1 and SNAI1 was significantly associated with shorter OS and/or PFS.
    DOI:
    10.3389/fonc.2022.1060864